Dynatronics Corporation (NASDAQ: DYNT) and Mazor Robotics (NASDAQ:MZOR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.


This table compares Dynatronics Corporation and Mazor Robotics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Dynatronics Corporation -5.47% -88.57% -9.59%
Mazor Robotics -37.66% -28.51% -22.75%

Volatility & Risk

Dynatronics Corporation has a beta of -0.01, meaning that its share price is 101% less volatile than the S&P 500. Comparatively, Mazor Robotics has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500.

Institutional and Insider Ownership

17.5% of Dynatronics Corporation shares are held by institutional investors. Comparatively, 25.7% of Mazor Robotics shares are held by institutional investors. 51.8% of Dynatronics Corporation shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for Dynatronics Corporation and Mazor Robotics, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics Corporation 0 0 0 0 N/A
Mazor Robotics 2 5 1 0 1.88

Mazor Robotics has a consensus target price of $39.60, suggesting a potential downside of 38.66%. Given Mazor Robotics’ higher possible upside, analysts clearly believe Mazor Robotics is more favorable than Dynatronics Corporation.

Valuation & Earnings

This table compares Dynatronics Corporation and Mazor Robotics’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Dynatronics Corporation $35.76 million 0.32 -$836,282.00 ($1.24) -1.98
Mazor Robotics $48.85 million 33.83 -$18.28 million ($0.79) -81.72

Dynatronics Corporation has higher revenue, but lower earnings than Mazor Robotics. Mazor Robotics is trading at a lower price-to-earnings ratio than Dynatronics Corporation, indicating that it is currently the more affordable of the two stocks.


Mazor Robotics beats Dynatronics Corporation on 8 of the 12 factors compared between the two stocks.

Dynatronics Corporation Company Profile

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.

Mazor Robotics Company Profile

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.

Receive News & Ratings for Dynatronics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.